Skip to main content
. 2018 Jul 21;22(4):317–322. doi: 10.1016/j.bjid.2018.06.004

Table 2.

SVR rates according to different therapeutic regimens.

Therapeutic regimens n (%) SVR; n (%) p-Value
PEG/RIB/SOF 31 (3.1) 28 (90.3)
SOF/DAC 286 (28.5) 266 (93.0)
SOF/DAC/RIB 435 (43.4) 415 (95.4)
SOF/RIB 59 (5.8) 54 (91.5)
SOF/SIM 156 (15.6) 138 (88.5)
SOF/SIM/RIB 35 (3.5) 35 (100.0)



Total 1002 (100.0) 936 (93.4) 0.478

PEG, pegylated interferon; RIB, ribavirin; SOF, sofosbuvir; DAC, daclatasvir; SIM, simeprevir.